General data protection regulation hinders global biomedical research

October 01, 2020

The European Union (EU) General Data Protection Regulation (GDPR) was designed to give EU citizens greater protection and control of their personal data, particularly when transferred to entities outside the EU. However, in a Policy Forum, Jasper Bovenberg and colleagues argue that current interpretations of the GDPR overly limit data sharing outside of the EU, which has hampered global biomedical research, including essential efforts to address COVID-19. To remedy this, Bovenberg et al. propose amendments for consideration by the EU Commission in its upcoming review of GDPR and urge the European Data Protection Board (EDPB) - the GDPR's governing body - to reevaluate recent guidance on COVID-19 related research. According to the authors, current interpretations of the GDPR fail to recognize how personal data is used in biomedical research; typically, it's used to derive generalized knowledge that benefits society and is applied in ways that pose negligible privacy risks to data subjects. Thus, the balance between an individual's privacy and the benefit to society in research contexts is quite different from others, such as commercial and marketing endeavors that seek to create profiles of individuals and their behaviors. As a result, the GDPR has frustrated data sharing in global biomedical research since its advent in 2018. Unfortunately, say the authors, recent EDPB guidelines concerning COVID-19 lack both urgency and consideration for the greater public good and fail to account for scientific considerations. "We believe that our recommendations can help to redress the unfortunate consequences created by the existing GDPR approach to international transfers of research data and will enable the biomedical research community to share data beyond the EU for scientific research, while ensuring a high level of protection for data subjects," write the authors.
-end-


American Association for the Advancement of Science

Related Biomedical Research Articles from Brightsurf:

General data protection regulation hinders global biomedical research
The European Union (EU) General Data Protection Regulation (GDPR) was designed to give EU citizens greater protection and control of their personal data, particularly when transferred to entities outside the EU.

Novel educational program puts a human face on biomedical research
The goal of translational research is to speed research breakthroughs into clinical practice.

Biomedical research may miss key information by ignoring genetic ancestry
A new study of Black residents of four distinct US cities reveals variations in genetic ancestry and social status that underscore the inadequacy of using skin color as a proxy for race in research.

Advances in cryo-EM materials may aid cancer and biomedical research
Cryogenic-Electron Microscopy (cryo-EM) has been a game changer in the field of medical research, but the substrate, used to freeze and view samples under a microscope, has not advanced much in decades.

World-first program uncovers errors in biomedical research results
Just like the wrong ingredients can spoil a cake, so too can the wrong ingredients spoil the results in biomedical research.

Scientists poised to study reproducibility of Brazilian biomedical research
A project to assess the reproducibility of biomedical research in Brazil has been described today in the open-access journal eLife.

Transparency and reproducibility of biomedical research is improving
New research publishing Nov. 20 in the open-access journal PLOS Biology from Joshua Wallach, Kevin Boyack, and John Ioannidis suggests that progress has been made in key areas of research transparency and reproducibility.

As private funding of biomedical research soars, new risks arise
Academic medical centers (AMCs) in the US are navigating an increasing shift in research funding from historic public funding (e.g., NIH) to private sources such as pharma and biotech companies, foundations, and charities, raising a host of new issues related to collaborative research models, intellectual property rights, and scientific and ethical oversight.

BGRF scientists co-publish research paper on blockchain & AI for biomedical applications
Biogerontology Research Foundation Chief Science Officer (CSO) co-authored the landmark paper in the journal Oncotarget on the convergence of blockchain and AI to decentralize and galvanize healthcare and biomedical research.

Promising new drug for Hep B tested at Texas Biomedical Research Institute
Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

Read More: Biomedical Research News and Biomedical Research Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.